Green Cross

Total investments

9

Average round size

10M

Portfolio companies

8

Rounds per year

0.16

Lead investments

1

Follow on index

0.11

Exits

1

Areas of investment
BiotechnologyArtificial IntelligenceHealth CareGeneticsMedical DeviceMedicalInsurTechLife SciencePharmaceuticalTherapeutics

Summary

In 1967 was created Green Cross, which is appeared as Corporate Investor. The company was established in Asia in South Korea. The leading representative office of defined Corporate Investor is situated in the Yongin.

The important activity for fund was in 2018. The real fund results show that this Corporate Investor is 5 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Green Cross, startups are often financed by Triathlon Medical Venture Partners, SparkLabs Accelerator, Early Stage Partners. The meaningful sponsors for the fund in investment in the same round are Tong Yang Venture Capital, Smilegate Investment, SBI Investment.

The fund has no exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Artificial Intelligence, Genetics. Among the most popular portfolio startups of the fund, we may highlight Juventas Therapeutics, PharmAbcine, Genoplan. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

Show more

Investments analytics

Analytics

Total investments
9
Lead investments
1
Exits
1
Rounds per year
0.16
Follow on index
0.11
Investments by industry
  • Health Care (7)
  • Biotechnology (6)
  • Life Science (4)
  • Therapeutics (3)
  • Artificial Intelligence (2)
  • Show 7 more
Investments by region
  • South Korea (5)
  • United States (4)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Doing Lab 31 May 2020 Software, Artificial Intelligence, Apps Seed 1M Seoul-t'ukpyolsi, Seocho, South Korea
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.